MCF Advisors’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,564
Closed -$4.63K – 1195
2026
Q2
$4.63K Hold
3,564
– – ﹤0.01% 1178
2026
Q1
$5.17K Hold
3,564
– – ﹤0.01% 1086
2025
Q4
$4.92K Hold
3,564
– – ﹤0.01% 946
2025
Q3
$9.7K Hold
3,564
– – ﹤0.01% 701
2025
Q2
$12.4K Hold
3,564
– – ﹤0.01% 617
2025
Q1
$13.1K Sell
3,564
-2,000
-36% -$7.3K ﹤0.01% 610
2024
Q4
$8.96K Hold
5,564
– – ﹤0.01% 676
2024
Q3
$4.23K Hold
5,564
– – ﹤0.01% 766
2024
Q2
$10K Hold
5,564
– – ﹤0.01% 641
2024
Q1
$26.5K Hold
5,564
– – ﹤0.01% 482
2023
Q4
$16.1K Sell
5,564
-100
-2% -$158 ﹤0.01% 539
2023
Q3
$7.65K Hold
5,664
– – ﹤0.01% 613
2023
Q2
$12.2K Hold
5,664
– – ﹤0.01% 538
2023
Q1
$16.5K Sell
5,664
-12,000
-68% -$60.5K ﹤0.01% 501
2022
Q4
$121K Buy
17,664
+5,000
+39% +$23.6K 0.01% 250
2022
Q3
$40K Sell
12,664
-2,900
-19% -$10.5K ﹤0.01% 359
2022
Q2
$50K Hold
15,564
– – 0.01% 319
2022
Q1
$47K Buy
+15,564
New +$52.6K ﹤0.01% 336
2021
Q4
– Sell
-26,564
Closed -$174K – 600
2021
Q3
$174K Buy
26,564
+24,564
+1,228% +$236K 0.02% 198
2021
Q2
$32K Sell
2,000
-3,000
-60% -$41.5K ﹤0.01% 338
2021
Q1
$62K Buy
+5,000
New +$76.6K 0.01% 251

Other funds holding STIM

MCF Advisors's STIM Position: Q3 2026 in Review

MCF Advisors sold out of Neuronetics (STIM) in Q3 2026, closing a stake of 3,564 shares — an estimated $4.63K sold.

MCF Advisors first reported a position in STIM in Q1 2021 and held it in 21 quarters. The position peaked at $174K in Q3 2021. 10 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • MCF Advisors reported no remaining Neuronetics position as of Q3 2026 after selling out during the quarter.
  • MCF Advisors sold 3,564 Neuronetics shares in Q3 2026, an estimated $4.63K.
  • MCF Advisors first reported a position in Neuronetics in Q1 2021 and held it in 21 quarters.
  • MCF Advisors's Neuronetics position peaked at $174K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on MCF Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.